Immunohistochemistry in the diagnosis of neoplasms of the central nervous system

Seminars in Diagnostic Pathology

Volumn 17, Issue 3, 2000, Pages 204-215

  Morrison, C D ^a   Prayson, R A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Brain; Central nervous system; Immunohistochemistry; Tumor

Indexed keywords

ACID PROTEIN; BIOCHEMICAL MARKER; CYCLINE; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; NEUROFILAMENT PROTEIN; PROTEIN P53; TUMOR MARKER;

CANCER GRADING; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM TUMOR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; NEUROEPITHELIOMA; PRIORITY JOURNAL; REVIEW;

ANTIBODIES; CENTRAL NERVOUS SYSTEM NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; NERVE TISSUE PROTEINS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033899863     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (172)

1. An acidic protein isolated from fibrous astrocytes
2. Immunohistochemistry: Techniques and applications to neurooncology
3. Immunohistochemistry of central nervous system tumors
4. Intermediate filament expression in astrocytic neoplasms
5. Current diagnostic concepts of astrocytic tumors
6. Anaplasia and heterogeneity of GFAP expression in gliomas
7. GFAP and S-100 protein levels as an index for malignancy in human gliomas and neurinomas
8. Differential expression of glial- and neuronal-associated antigens in human tumors of the central and peripheal nervous system
9. Non-glial specificities of immunohistochemistry for the glial fibriltary acidic protein (GFAP)
10. An immunohistotogical study of 66 ependymomas
11. Immunohistochemical study of ependymal neoplasms: Histological subtypes and glial and epithelial characteristics
12. Perivascular pseudorosettes in childhood brain tumours: An ultrastructural and immunohistochemical study
13. Distribution of epithelial membrane antigen in normal and neoplastic human ependyma
14. Epithelial membrane antigen expression in ependymomas
15. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: Gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma
16. Ultrastructural characterization of transitional cells in oligodendrogliomas
17. Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas
18. Clinicopathologic correlations in oligodendrogliomas
19. Ultrastructural and immunohistochemical segregation of gemistocytic subsets
20. Oligodendroglial tumors: An immunohistochemical and electron microscopic study
21. Immunohistochemical characterization of oligodendrogliomas: An analysis of multiple markers
22. Gliosarcoma: A histologic and immunohistochemical reaffirmation
23. Glisarcoma: An immunohistochemical study
24. Histogenesis of the sarcomatous component of the gliosarcoma: An ultrastructural study
25. Gliosarcoma: A study of 13 tumors including p53 and CD34 immunohistochemistry
26. Primitive neurocctodermal tumors of the central nervous system: Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins
27. Adult cerebellar medulloblastomas: The pathological, radiographic, and clinical disease spectrum
28. Primitive neuroectodermal tumors of the central nervous system express all classes of intermediate filaments
29. Differentiation in the medulloblastoma. A histological and immunohistological study
30. Medulloblastoma. An immunohistological study of 50 cases
31. Primitive neuroectodermal tumors including the medulloblastoma: Glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma
32. Medulloblastoma
33. Glial fibrillary acidic protein in medulloblastoma
34. Immunohistochemical and ultrastrucrural observations on Homer Wight (neuroblastic) rosettes and the 'pale islands' of human cerebellar medulloblastomas
35. Cerebellar desmoplastic medulloblastomas. A further immunohistochemical characterization of the reticulin-free pale islands
36. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors
37. The prognostic significance of glial fibrillary acidic protein Staining in medulloblastoma
38. A 38,000-dalton membrane protein (p38) present in presynaptic vesicles
39. Identification and localization of synaptophysin, an integral membrane glycoprotein of M(T) 38,000 characteristic of presynaptic vesicles
40. Synaptophysin: A marker protein for neuroendocrine cell neoplasms
41. Synaptophysin: A sensitive and specific marker for ganglion cells in central nervous system neoplasms
42. An immunohistochemical study of the primitive and maturing elements of human cerebral medullocpitheliomas
43. Immunohistochemistry of a spontaneous murine ovarian teratoma with neuroepithelial differentiation. Neuronal-associated beta-tubulin as a marker for primitive neuroepithelium
44. Synaptophysin staining in normal brain: Importance for diagnosis of ganglioglioma
45. Epiperikaryal synaptophysin reactivity in the normal human central nervous system
46. Central nervous system gangliogliomas: Part 1: Pathology
47. A clinicopathologic and immunomorphologic study of 13 cases of ganglioglioma
48. Pleomorphic xanthoastrocytoma: A distinctive meningocerebral glioma of young subjects with a relatively favourable prognosis. A study of 12 cases
49. The pleomorphic xanthoastrocytoma and its differential diagnosis: A study of five cases
50. Pleomorphic xanthoastrocytoma: The birth of a diagnosis and a concept
51. Pleomorphic xanthoastrocytoma: Ultrastructural, immunohistochemical, and DNA cytofluorometric study of a case
52. Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for an neuronal element and possible relationship to ganglion cell tumors
53. Association of pleomorphic xanthoastrocytoma with cortical dysplasia and neuronal tumors - A report of three cases
54. Composite pleomorphic xanthoastrocytoma and ganglioglioma: Report of four cases and review of the literature
55. Pleomorphic xanthoastrocytoma with a gangliogliomatous component
56. Association of pleomorphic xanthoastrocytoma with cortical dysplasia and neuronal tumors. A report of three cases
57. Pleomorphic xanthoastrocytomas a component of a cerebellar ganglioglioma. Case report
58. Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies
59. Central neurocytoma: Immunohistochemical and ultrastructural study
60. Central neurocytoma. A clinicopathological, immunohistochemical and ultrastructural study of 7 cases
61. An immunohistological study of 66 ependymomas
62. Immunohistochemical characterization of primitive neuroectodermal tumors and their possible relationship to the stepwise ontogenetic development of the central nervous system
63. Neuron-associated class III beta-tubulin, Retinal S-antigen, synaptophysin, and glial fibriliary acidic protein in human medulloblastomas: A clinicopathological analysis of 36 cases
64. Molecular markers of primitive neuroectodermal tumors (PNETs) and other pediatric central nervous system tumors
65. Medulloblastoma: A population based study of 532 cases
66. A clinicopathologic and immunohistochemical analysis of 53 cases of medulloblastoma with emphasis on synaptophysin expression
67. Differential expression of neurofilament triplet proteins in brain developmen
68. Changes in intermediate filament composition during neurogenesis
69. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ
70. Structure and utilization of tubulin isotypes
71. Limited tissue distribution of a novel beta-tubulin isoform
72. Microtubule-associated proteins: Their potential role in determining neuronal morphology
73. Expression of microtubule-associated proteins, Map-1 and Map-2, in human neuroblastomas and the differential diagnosis of immature neuroblasts
74. Characterization of human brain S-100 fraction: Amino acid sequence of S-100β
75. An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues
76. Cellular immunolocalization of S-100 protein within fixed tissue sections by monoclonal antibodies
77. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors
78. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors
79. Immunohistochemical profile Of meningiomas and their histological subtypes
80. Meningiomas. An immunohistochemical study of 50 Cases
81. Epithelial differentiation in meningiomas. An immunohistochemical, histochemical, and ultrastructural study. With review of the literature
82. Meningiomas: Diagnostic value of immunoperoxidase staining for epithelial membrane antigen
83. A new antigen on the epithelial membrane: Its immunoperoxidase localization in normal and neoplastic tissue
84. Epithelial membrane antigen: A diagnostic discriminant in surgical pathology: Immunohistochemical profile in epithelial, mesenchymal and hematopoietic neoplasms using paraffin sections and monoclonal antibodies
85. Meningioma, meningeal hemangiopericytoma (angioblastic meningioma), peripheral hemangiopericytoma, and acoustic schwannoma. A comparitive immunohistochemical study
86. Chordoma: An immunohistochemical study of 20 cases
87. Immunohistochemical distinction of classic and chondroid chordomas
88. Chordoma with a massive Spindlecell sarcomatous transformation. A light- and electron-microscopic and immunohistological study
89. Dedifferentiated chordoma. A clinicopathologic and immunohistochemical study of three cases
90. Chordomas with malignant spindle cell components
91. Recent applications of immunoperoxidase histochemistry in human neuro-oncology
92. Hemanglobtastomas of the central nervous system. A 10-year study with special reference to yon Hippel-Lindau syndrome
93. Cerebellar hemangioblastoma: Immunohistochemical distinction from metastatic renal celt carcinoma
94. Immunohistochemistry of capillary hemangioblastoma. Immunoperoxidase-labeled antibody staining resolves the differential diagnosis with metastatic renal cell carcinoma, but does not explain the histogenesis of the capillary hemangioblastoma
95. Keratin intermediate filament expression in astrocytic neoplasms: Analysis by Immunocytochemistry, Western blot, and northern hybridization
96. Keratin immunoreactivity in glial neoplasms
97. Cytokeratin immunoreactivity in gliomas
98. Intermediate filament expression in astrocytic neoplasms
99. Keratin expression in astroacytomas: An immunoflourescent and biochemical reassessment
100. Evaluation of epithelioid and keratin markers in glioblastoma multiforme: An immunohistochemical study
101. Metastatic adenocarcinoma to the brain: An immunohistochemical approach
102. Choroid plexus papillomas: An immunohistological study of 16 cases
103. Ependymal and choroid plexus tumors: Cytokeratin and GFAP expression
104. Intermediate filament proteins in choroid plexus and ependyma and their tumors
105. Choroid plexus neoplasms: Clinicopathologic and immunohistochemical studies
106. Clinicopathologic correlations in epithelial choroid plexus neoplasms: A study of 52 cases
107. The use of immunomorphology to differentiate choroid plexus tumors from metastatic carcinomas
108. Choroid plexus epithelium (normal and neoplastic) express synaptophysin. A potentially useful aid in differentiating carcinoma of the choroid plexus from metastatic papillary carcinomas
109. Primary central nervous system lymphomasupdate - An update
110. The French Study group for HIV-associated tumors AIDS-related primary brain lymphomas: Histopathologic and immunohistochemical study of 51 cases
111. Central nervous system lymphomas in organ allograft recipients
112. CD20: A review
113. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel
114. Ki-1 positive large cell lymphomas, a heterogenous group of neoplasms. Morphologic, immunophenotypic, genotypic and clinical features of 24 cases
115. Macrophages markers in diagnostic neuropathology
116. Immunostaining for alpha-1-antichymotrypsin and alpha 1-antitrypsin in gliomas
117. Novel interactions between dermal dendrocytes and mast cells in human skin. Implications for hemostasis and matrix repair
118. Factor XIIIa immunoreactivity in tumors of central nervous system
119. Langerhans cellhistiocytosis of the hypothalalmus: Diagnostic value of immunohistochemistry
120. Sinus histiocytosis (Rosai-Dorfman disease) clinically limited to the skin. An immunohistochemical and ultrastructural study
121. Practical applications of immunohistochemistry in hematolymphoid neoplasms
122. Melanoma-associated antigens in tumours of the nervous system: An immunohistochemical study with the monoclonal antibody HMB-45
123. Psammomatous melanotic schwannoma, A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome
124. Melanotic cerebral astrocytoma: Case report and literature review
125. Melanotic medulloblastoma: A Case report with immunohistochemical and ultrastructural examination
126. Primary spinal paragangliomas: A clinicopathological and immunohistochemical study of 30 cases
127. A comparative morphological and immunohistochemical study of testicular seminomas and intracranial germinomas
128. Immunohistochemical differences between intracranial germinomas and their gonadal equivalents. An immunoperoxidase study of germ ceil tumors with epithelial antigen, cytokeratin, and vimentin
129. Intracranial germ cell tumors: Pathobiological and immunohistochemical aspects of 70 cases
130. Primary intracranial germ cell tumor: Pathologic study of 51 patients
131. Progesterone receptor expression in meningiomas
132. Progesterone and estrogen receptors in meningiomas: Prognostic considerations
133. Immunohistochemical detection of female sex hormone receptors in meningiomas: Coorelation with clinical and histological features
134. Expression of the CD34 gene in vascular endothelial cell
135. Solitary fibrous tumor of the meninges: A lesion distinct from fibrous meningioma
136. The immunophenotypic spectrum of meningeal hemangiopericytoma: A comparison with fibrous meningioma and solitary fibrous tumor of meninges
137. CD34 and epithelial membrane antigen distinguish dural hemangiopericytoma and meningioma
138. Transthyretin: A choroid plexusspecific transport protein in human brain
139. A marker for primary choroid plexus neoplasms
140. Transthyretin immunoreactivity in choroid plexus neoplasms and brain metastases
141. Paraganglioma of the cauda equina region: Clinicopathologic study of 31 cases with special reference to immunocytology and ultrastructure
142. Prognostic analysis of astrocytic gliomas correlating histological parameters with the proliferating cell nuclear antigen labelling index (PCNA-LI)
143. Prognostication of astrocytoma patient survival by Ki-67 (Mib-1), PCNA, and S-phase fraction using archival paraffin-embedded samples
144. Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: Relationships and prognostic value
145. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: Correlation with histological type and tumor grade
146. Image cytometric measurement of nuclear proliferation markers (Mib-1, PCNA) in astrocytomas
147. Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms
148. Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in gliomas
149. Ki-67 immunoreactivity in human central nervous system tumors: A study with Mib-1 monoclonal antibody on archival material
150. Cell cycle analysis of a cellproliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67
151. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody Mib-1
152. Prognostic significance of Ki-67 labeling indices obtained using Mib-1 monoclonal antibody in patients with supratentorial astrocytomas
153. MIB-1 proliferation index predicts survival among patients with grade II astrocytoma
154. A comparison of the predictive power for survival on gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters
155. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms
156. Changes in proliferating cell nuclear antigen expression in glioblastoma multiforme cells along a stereotactic biopsy trajectory
157. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index
158. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas
159. The role of p53 in cell cycle regulation
160. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression
161. Prognostic significance of p53 immunoreactivity in adult patients with supratentorial fibrillary astrocytic neoplasms
162. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme
163. Analysis of p53 gene mutations in low and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry
164. Pattern of mutant p53 expression in human astrocytomas suggests the existence of alternate pathways of tumorigenesis
165. Paraffin section p53 protein immunohistochemistry in neuroectodermal tumors
166. p53 Protein expression in central nervous system tumors: An immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies
167. Immunocytochemical detection of p53 in human gliomas
168. p53 Mutations in nonastrocytic human brain tumors
169. The p53 gene and protein in human brain tumors